openPR Logo
Press release

Global Heart Valve Disease Treatment Market Competitive Strategies and Worldwide Demand with Top players- F. Hoffmann-La Roche Ltd, Bayer AG, Medtronic, Johnson & Johnson Services, Inc, Boehringer Ingelheim International GmbH

01-15-2020 10:21 AM CET | Health & Medicine

Press release from: Data Bridge Market Research

Global Heart Valve Disease Treatment Market

Global Heart Valve Disease Treatment Market

Heart valve disease treatment market­ is expected to grow at a substantial CAGR in the forecast period of 2020-2027. The report contains data of the base year 2019 and historic year 2018. This rise in market value can be attributed to the increasing geriatric population and increasing adoption of an unhealthy lifestyle.

Get Sample Report + All Related Graphs & Charts @https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-heart-valve-disease-treatment-market

Major Market Players:

The major market players in the heart valve disease treatment market­ are Abbott, Pfizer Inc, Eli Lilly and Company, AstraZeneca, F. Hoffmann-La Roche Ltd, Bayer AG, Medtronic, Johnson & Johnson Services, Inc, Boehringer Ingelheim International GmbH, CSL Limited, CryoLife, Inc, Mardil Medical, Inc, NeoChord, Inc, Edwards Lifesciences Corporation, SYNECOR, Foldex, Inc, LivaNova PLC, Novosense AB, Servier among others.

Global Heart Valve Disease Treatment Market­ By Type (Valvular Stenosis and Valvular Insufficiency), Treatment (Medication and Surgery), Drugs Class (Diuretics, Anti-Arrhythmic Medications, Vasodilators, ACE Inhibitors, Beta Blockers, Anticoagulants and Others), Route of Administration (Oral, Intravenous and Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Geography (North America, Europe, South America, Asia-Pacific, Middle East and Africa) - Industry Trends and Forecast to 2027

Competitive Analysis:

Heart valve disease treatment market­ is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of heart valve disease treatment market ­for Global Europe, North America, Asia-Pacific, South America and Middle East & Africa.

Market Outlook: Global Heart Valve Disease Treatment Market­

Heart valve disease is also known as valvular heart disease impairment in the functioning of the valves of the heart. It causes by either valvular stenosis or valvular insufficiency. In some cases one or more of the valves don’t work properly, these results in the disruption of the blood flow in the body. Symptoms include abnormal heart sound (murmur), shortness of breath, fatigue, swelling of ankles and feet, dizziness and fainting.

According to the John Muir Health, heart disorder is the leading cause of death in the U.S, with more than 600,000 deaths in America each year and heart valve disease gets diagnosed in over five million Americans each year.

Market Drivers

Rapid development of invasive cardiology and the adoption of minimally invasive techniques for heart surgery boosting the market growth
Rising research & development in valve replacement and adult cardiac surgery such as treatment for valvular heart diseases is accelerating the market growth in the forecast period
Improvement of healthcare infrastructure in developing economies is enhancing the market growth for heart valve disease treatment

Market Restraints

High cost of diagnostics and surgeries is hindering the market
Stringent government regulations and medical authorities is hampering the market growth in the near future
Lack of experts and medical practitioners for heart surgery is restraining the market growth

Grab Your Report at an Impressive 30% Discount! Please click here@https://www.databridgemarketresearch.com/request-a-discount/global-heart-valve-disease-treatment-market

 Global Heart Valve Disease Treatment Market­ Scope and Market Size:

Heart valve disease treatment market is segmented on the basis of types, treatment, drugs class, route of administration, distribution channel and end-users. The growth among these specific segments will help users analyze niche pockets of growth and strategies to approach the market and determine your core application areas and difference in your target markets.

Based on treatment, the heart valve disease treatment market is segmented into medication and surgery

Based on types, the heart valve disease treatment market is segmented into valvular stenosis and valvular insufficiency

Based on drugs class, the heart valve disease treatment market is segmented diuretics, anti-arrhythmic agents, vasodilators, ace inhibitors, beta blockers, anticoagulants and others

Based on the route of administration, the heart valve disease treatment market is segmented into oral, intravenous and others.

Based on the distribution channel, the heart valve disease treatment market is segmented as hospital pharmacy, online pharmacy, retail pharmacy

Based on end-users, the heart valve disease treatment market is segmented into hospitals, homecare, specialty clinics and others

Global Heart Valve Disease Treatment Market­ Country Level Analysis

The countries covered in the market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific in Asia-Pacific, Saudi Arabia, U.A.E, South Africa, Israel, Egypt, Kuwait, Rest of Middle East and Africa as a part of Middle East and Africa, Argentina, Brazil, Peru and Rest of South America as part of South America.

Key Developments in the Market

In March 2019, Abbott Vascular Inc a subsidiary of Abbott received expanded approval from the U.S FDA for MitraClip Clip Delivery System, a valve repair device to treat certain heart failure patients with mitral regurgitation. Previously this device is indicated for reducing mitral regurgitation in patients with abnormalities of the mitral valve. This expanded approval of new indication will benefit the patients with heart failure symptoms associated with significant secondary mitral regurgitation, who have received inadequate response from other therapies.
In August 2019, Medtronic received expanded approval from the FDA for the devices CoreValve Evolut R and CoreValve Evolut PRO for the several transcatheter heart valves in patients who have low risk for death and complication associated with open-heart surgery. The approvals expand the clinical use of these devices and broaden the company’s portfolio in the therapeutics area of cardiology.

Reasons to Purchase this Report

Current and future of global heart valve disease treatment market­ outlook in the developed and emerging markets.
The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period.
Regions/Countries that are expected to witness the fastest growth rates during the forecast period.
The latest developments, market shares, and strategies that are employed by the major market players.

Note: If you have any special requirements, please let us know and we will offer you the report as you want.

Contact:

Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475

Email: Corporatesales@databridgemarketresearch.com

About Data Bridge Market Research:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Heart Valve Disease Treatment Market Competitive Strategies and Worldwide Demand with Top players- F. Hoffmann-La Roche Ltd, Bayer AG, Medtronic, Johnson & Johnson Services, Inc, Boehringer Ingelheim International GmbH here

News-ID: 1896616 • Views: 595

More Releases from Data Bridge Market Research

"Global Refinished Paint Market". | Rising In Demand !!
Data Bridge market Research has released a new report on Global Refinished Paint Market which incorporates a thorough assessment of overall Global Refinished Paint Market The report provides a detailed competitive analysis which includes the profiles of key market players and organizations and their working strategies. The report consists of essential data and information about the concerned Global Refinished Paint Market. For better understanding complex Global Refinished Paint Market data
The Global Portable Gas Chromatograph Market | Indepth PESTEL analysis, SWOT ana …
Data Bridge market Research has released a new report on Global Portable Gas Chromatograph Market which incorporates a thorough assessment of overall Global Portable Gas Chromatograph Market The report provides a detailed competitive analysis which includes the profiles of key market players and organizations and their working strategies. The report consists of essential data and information about the concerned Global Portable Gas Chromatograph Market . For better understanding complex Global
The Global Technical Textile Market | Huge Demand In this Sector!!
Data Bridge market Research has released a new report on Global Technical Textile Market which incorporates a thorough assessment of overall Global Technical Textile Market The report provides a detailed competitive analysis which includes the profiles of key market players and organizations and their working strategies. The report consists of essential data and information about the concerned Global Specialty Gas Market. For better understanding complex Global Technical Textile Market data
Global In-Vitro Fertilization Services Market Recent Trends, In-depth Analysis, …
Global In-Vitro Fertilization Services Market By Cycle Type (Fresh IVF Cycle, Thawed IVF Cycles, Donor Egg IVF Cycles), End-User (Fertility Clinics, Hospitals, Surgical Centers, and Clinical Research Institutes), and Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) - Industry Trends & Forecast to 2026 Global in-vitro fertilization services market is expected to rise to an estimated value of USD 25.18 billion by 2026, registering a substantial CAGR in

All 5 Releases


More Releases for Heart

Heart Congress 2019
Coalesce Research Group proudly announces the “International Conference on Heart & Clinical Cardiology Research” at Osaka, Japan during November 14-15, 2019. This Conference will be perfect platform for scientists, professors, healthcare professionals and cardiologists. Heart Congress 2019 is designed to provide diverse and recent research education on cardiovascular disease that keeps medical professionals along with issues heartrending on diagnosis, treatment of Cardiac disorders and prevention. In recent years, cardiac and
Heart Pump Device Market - Potential Innovations 2025 | Terumo, Jarvik Heart
Heart Pump Device Market: Snapshot Heart pump devices are essentially mechanical pumps playing the role of ventricular assist devices. These are surgically implanted and are used for temporarily supporting the functions of heart in people with weak heart or irregular blood flow. These devices are notably used as a bridge to cardiac transplantation for patients suffering with end stage heart failure. They can also be used in patients during and after
Congestive Heart Failure (Heart Failure) - Pipeline Review, H2 2017
ReportsWorldwide has announced the addition of a new report title Congestive Heart Failure (Heart Failure) - Pipeline Review, H2 2017 to its growing collection of premium market research reports. Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Congestive Heart Failure (Heart Failure) - Pipeline Review, H2 2017, provides an overview of the Congestive Heart Failure (Heart Failure) (Cardiovascular) pipeline landscape. Heart failure is also known as congestive heart failure (CHF).
Congestive Heart Failure (Heart Failure) Market Research Report
Latest industry research report on: Congestive Heart Failure (Heart Failure) Market | Industry Size, Share, Research, Reviews, Analysis, Strategies, Demand, Growth, Segmentation, Parameters, Forecasts GlobalData's clinical trial report, Congestive Heart Failure (Heart Failure) Global Clinical Trials Review, H1, 2017" provides an overview of Congestive Heart Failure (Heart Failure) clinical trials scenario. This report provides top line data relating to the clinical trials on Congestive Heart Failure (Heart Failure). Report includes an
Prosthetic Heart Valve Market
Prosthetic (artificial) heart valve refers to a device implanted in the heart of a patient suffering from valvular heart disease. A cardiac surgery is performed to replace the abnormal heart valve with a prosthetic heart valve. Replacement of a diseased valve with a prosthetic heart valve results in reduction in morbidity and mortality associated with the cardiac valve disorder. When the treatment of heart valve disease reaches a stage where
Global Heart Implants Market
The Heart Implants Market report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies. In a growing cardiac implants market where profits and growth prospects run together, many companies are vying to plunge into this untapped market. Heart implants are end-stage operations, where a failing